SRC at the crossroads of KRAS inhibitor resistance: Mechanisms and therapeutic opportunities is a research paper published in Cancer Letters (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Lung Association
Grant: 821321
U.S. Department of Defense
Grant: RA210084
U.S. Department of Defense
Grant: R01 HL177140
U.S. Department of Defense
Grant: RSG-19-166-01-TB
U.S. Department of Defense
Grant: R01 GM144890
U.S. Department of Defense
Grant: R21 CA259706
U.S. Department of Defense
Grant: R01 CA258614
Tobacco-Related Disease Research Program
Grant: R01CA244341
Tobacco-Related Disease Research Program
Grant: T33IR6461
American Cancer Society Inc
Grant: IRG-21-142-16
Anna Fuller Fund
Grant: 21005962
Cancer Prevention and Research Institute of Texas
Grant: RP220145
National Institutes of Health
Grant: R01CA229275
National Institutes of Health
Grant: R01CA265827
National Institutes of Health
Grant: R01CA160417
National Institutes of Health
Grant: R01CA211070
National Institutes of Health
Grant: R21CA259243